Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Miossec

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Current Rheumatology Reports|February 22, 2012
Interleukin-17 in inflammatory myopathiesAnne Tournadre, Pierre Miossec
Nature Reviews. Rheumatology|March 13, 2013
A critical role for immature muscle precursors in myositisAnne Tournadre, Pierre Miossec
Arthritis Research & Therapy|September 10, 2022
Synoviocytes and skin fibroblasts show opposite effects on IL-23 production and IL-23 receptor expression during cell interactions with immune cellsMélissa Noack, Pierre Miossec
Autoimmunity Reviews|July 28, 2025
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritisAliki Zavoriti, Pierre Miossec
Arthritis Research & Therapy|July 4, 2025
IFNγ production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritisMélissa Noack, Pierre Miossec
Nature Reviews. Rheumatology|June 23, 2019
Systemic effects of IL-17 in inflammatory arthritisAudrey Beringer, Pierre Miossec
Cytokine|May 20, 2004
Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cellsCorinne Granet, Pierre Miossec
Biologics : Targets & Therapy|August 27, 2009
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapyHubert Marotte, Pierre Miossec
Frontiers in Medicine|January 30, 2019
IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive LevelsMarie Robert, Pierre Miossec
Arthritis Research & Therapy|February 26, 2004
Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritisMasanori Kawashima, Pierre Miossec
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Current Rheumatology Reports|February 22, 2012
Interleukin-17 in inflammatory myopathiesAnne Tournadre, Pierre Miossec
Nature Reviews. Rheumatology|March 13, 2013
A critical role for immature muscle precursors in myositisAnne Tournadre, Pierre Miossec
Arthritis Research & Therapy|September 10, 2022
Synoviocytes and skin fibroblasts show opposite effects on IL-23 production and IL-23 receptor expression during cell interactions with immune cellsMélissa Noack, Pierre Miossec
Autoimmunity Reviews|July 28, 2025
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritisAliki Zavoriti, Pierre Miossec
Arthritis Research & Therapy|July 4, 2025
IFNγ production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritisMélissa Noack, Pierre Miossec
Nature Reviews. Rheumatology|June 23, 2019
Systemic effects of IL-17 in inflammatory arthritisAudrey Beringer, Pierre Miossec
Cytokine|May 20, 2004
Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cellsCorinne Granet, Pierre Miossec
Biologics : Targets & Therapy|August 27, 2009
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapyHubert Marotte, Pierre Miossec
Frontiers in Medicine|January 30, 2019
IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive LevelsMarie Robert, Pierre Miossec
Arthritis Research & Therapy|February 26, 2004
Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritisMasanori Kawashima, Pierre Miossec
Pageof 16